PTSM: Pharmaceutical Technology Sourcing and Management-03-06-2013

Incremental innovation advances medicines by expanding therapeutic classes, increasing the number of available dosing options, discovering new physiological interactions of known medicines, and improving other properties of existing medicines

Contract API manufacturers and fine-chemical producers proceed with select investment in capacity and service additions.

Is the contract-only CMO an endangered species?

Supply-demand fundamentals show strong growth for generic APIs as gains in innovator APIs lag.

A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.